Q-Line Biotech
Q-Line Biotech Limited is an Indian in-vitro diagnostics company incorporated in 2010 and headquartered in New Delhi. The company manufactures and markets biochemistry reagents, consumables, point-of-care devices, and pathology equipment serving diagnostic laboratories, hospitals, and medical colleges through a B2B distribution model. Listed on NSE Emerge in May 2026, the company operates across 15+ countries with 150+ national and international clients and employs over 200 staff.
AMC arm of Abakkus Asset Manager, founded by Sunil Singhania, former CIO of Reliance Mutual Fund who oversaw the equity book when it was India's largest. Launched its maiden Flexi Cap Fund in December 2025, raising Rs 2,468 crore in the NFO alone, and crossed Rs 5,000 crore within months. The MF licence brings Sunil Singhania's quality small and midcap compounding philosophy to all retail investors.